On this episode of NMOSD Master Class, Dr. Jeffrey Bennett from the University of Colorado Anschutz Medical Center, addresses issues that may require changes in the selection or sequencing of disease modifying therapies in NMOSD.
Coming Soon
Jeffrey Bennett, MD, PhD
Professor of Neurology and Ophthalmology, University of Colorado Anschutz Medical Campus.
The Patient Health Alliance (PHA) is a source of information and education for NMOSD and related conditions. The content of the following presentation is based entirely on published data or expert opinion. PHA is not a clinical provider, and does not offer diagnostic, therapeutic or clinical care recommendations or advice on personal health. All patients and caregivers are advised to consult with their healthcare team for specific information.